CrushSCI.com
319.4Average days
244Median days
127Fastest days
603Longest days
6782025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

555 days

Study protocol for a randomized controlled multinational trial to analyze the effects of an app-based patient education textbook (Ready4OP App) to increase health literacy before major oncologic surgery and its potential effects on surgical outcomes in Slovenia, Spain, and Germany—the APERIO Trial

Authors
Svenja Sliwinski; Franziska J. Stickl; S. Fatima Faqar-Uz-Zaman; Charlotte Detemble; Dora Zmuc; Jan Zmuc; Gasper Pilko; Cristina Dopazo; Maria Martinez-Lopez; Armin Wiegering; Andreas A. SchnitzbauerShow moreShow less
Affiliations
1. Department for General, Visceral, Transplant and Thoracic Surgery, Frankfurt University Hospital, Goethe University Frankfurt/Main, Frankfurt Am Main, Germany; 2. Klinik Für Chirurgie, Ruhr Universität Bochum, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany; 3. MCL Medical Center Ljubljana, Ljubljana, Slovenia; 4. Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 5. Department of Hepatic and Biliary Surgery and Transplants, Vall d’Hebron Barcelona Hospital Campus, Barcelona, SpainShow moreShow less
Source PDF DOI Publisher page
199 days

Participation thresholds and recruitment milestones for HIV cure-related trials: a modified Delphi study

Authors
Ali Ahmed; Bridgette Picou; John A. Sauceda; Karine DubéShow moreShow less
Affiliations
1. Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, USA; 2. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 3. The Well Project, Palm Springs, USA; 4. Division of Prevention Science, Department of Medicine, University of California, San Francisco, San Francisco, USAShow moreShow less
Source PDF DOI Publisher page
241 days

Evaluating the efficacy and safety of therapeutic plasma exchange in snakebite-associated thrombotic microangiopathy compared to standard care alone: study protocol for a multicenter randomized controlled trial

Authors
Eranga Wijewickrama; Bhawani Yasassri Alvitigala; Lallindra Gooneratne; Ariaranee Gnanathasan; Dilushi Wijayaratne; Upul Senarath; Anjana Silva; Rajitha Abeysekera; Geoffrey Isbister; Tina Noutsos; Indika GawarammanaShow moreShow less
Affiliations
1. Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; 2. Department of Pathology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; 3. Department of Community Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; 4. Department of Parasitology, Faculty of Medicine and Allied Health Sciences, Rajarata University, Mihintale, Sri Lanka; 5. Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka; 6. Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; 7. Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, AustraliaShow moreShow less
Source PDF DOI Publisher page
317 days

Whole-course care intervention for patients with spinal cord injury: study protocol for a randomized controlled trial

Authors
Peipei Ding; Haoran Li; Hui Huang; Mengmeng Chen; Xiaoxiao Xia; Linsheng Feng; Qing Dai; Lunlan LiShow moreShow less
Affiliations
1. Department of Nursing, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 2. School of Nursing, Anhui Medical University, Hefei, China; 3. Department of Nursing, The Second Hospital of Nanjing, Nanjing, China; 4. Orthopedics, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 5. Human Resources Department, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaShow moreShow less
Source PDF DOI Publisher page
188 days

Personalized assistive EMG-controlled virtual reality interface combined with cerebellar-iTBS for post-stroke arm recovery (ERICA): study protocol for a three-arm randomized controlled trial

Authors
Matteo Nocilli; Alex Martino Cinnera; Danny Adrian Spampinato; Valentina Pezzopane; Silvia Silella; Giacomo Koch; Andrea d’Avella; Denise Jennifer BergerShow moreShow less
Affiliations
1. Laboratory of Neuromotor Physiology, LIFE - Institute for Research and Care - Santa Lucia IRCCS, Rome, Italy; 2. Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 3. Experimental Neuropsychophysiology Lab, LIFE - Institute for Research and Care - Santa Lucia IRCCS, Rome, Italy; 4. Saint Camillus International University of Health and Medical Sciences (UniCamillus), Rome, Italy; 5. Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; 6. Center for Translational Neurophysiology of Speech and Communication, Italian Institute of Technology (IIT), Ferrara, Italy; 7. Department of Biology, University of Rome Tor Vergata, Rome, Italy; 8. Department of Systems Medicine, Centre of Space Bio-Medicine, University of Rome Tor Vergata, Rome, Italy; 9. Department of Theoretical and Applied Sciences, Research Centre for Applied Psychology, e-Campus University, Novedrate (Como), ItalyShow moreShow less
Source PDF DOI Publisher page
527 days

ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with A myotrophic lateral sclerosis for the evaluation of efficacy and safety of B - C ell D epletion with rituximab (ABCD)

Authors
Friederike Ufer; Rosa Rössling; Annika Spottke; Robert Németh; Tamara Schaprian; Nadja Kemmerling-de Coninck; Anna Gamez; Rebecca Sterl; Pia Naumann; Nikolaus Behr; André Maier; Thomas Meyer; Patrick Weydt; Harald PrüssShow moreShow less
Affiliations
1. Department of Neurology and Experimental Neurology, Charité –Universitätsmedizin Berlin, Berlin, Germany; 2. German Center for Neurodegenerative Diseases E.V. (DZNE) Berlin, Berlin, Germany; 3. German Center for Neurodegenerative Diseases E.V. (DZNE) Bonn, Bonn, Germany; 4. Institute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany; 5. ALS and Motoneuron Disease Outpatient Clinic, Charité –Universitätsmedizin Berlin, Berlin, Germany; 6. Motoneuron Disease Outpatient Clinic, Neurozentrum, University Hospital Bonn, Bonn, GermanyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Trials take to review a manuscript?

As of 2026-11-19, CrushSCI has 21 complete review records for Trials. The fastest paper went from submission to acceptance in 127 days (The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) trial—rationale for the selected lower steroid dose, received 2026-03-06, accepted 2026-07-11); the slowest took 603 days. The average is 319.4 days and the median is 244 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.